Deep Medicine Acquisition Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of -$119,669,650 last year. Net change in cash is therefore -$281,563.
Cash Flow
| 2023 | -1.03M | 120.42M | -119.66M |
|---|
DMAQ Cash Flow Statement (2022 – 2022)
| 2022 | |
|---|---|
Cash at beginning of period | 877.09K |
Operating activities | |
Net income | -400.23K |
| Adjustments to reconcile net income to cash generated by operating activities: | |
Depreciation and amortization | 0 |
Stock-based compensation expense | 0 |
| Deferred income tax benefit | 0 |
| Changes in operating assets and liabilities: | |
Accounts receivable, net | 0 |
Inventories | 0 |
Accounts payable | 0 |
Cash generated by operating activities | -1.03M |
Investing activities | |
Purchases Of Investments | 0 |
Investments In Property Plant And Equipment | 0 |
Acquisitions Net | 0 |
Cash generated by investing activities | 120.42M |
Financing activities | |
Common Stock Issued | 0 |
Payments for dividends | 0 |
Repurchases of common stock | -121.03M |
Repayments of term debt | 0 |
Cash used in financing activities | -119.66M |
Net Change In Cash | -281.56K |
Cash at end of period | 595.53K |
| Data source |